Inventor · disambiguated record
Viktor S. Goldmakher
Also filed as: GOLDMAKHER VIKTOR · GOLDMAKHER VIKTOR S
20 granted patents·6 pending applications·2,091 citations·filing 1994–2020
97Inventor score
Top patents by PatentIndex Score
26 records- 0199US5846545ATargeted delivery of cyclopropylbenzindole-containing cytotoxic drugsIMMUNOGEN INC·Filed 1995·Granted Dec 8, 1998·531 cites·57 claims
- 0299US5585499ACyclopropylbenzindole-containing cytotoxic drugsIMMUNOGEN INC·Filed 1995·Granted Dec 17, 1996·541 cites·8 claims
- 0399US5475092ACell binding agent conjugates of analogues and derivatives of CC-1065IMMUNOGEN INC·Filed 1994·Granted Dec 12, 1995·668 cites·8 claims
- 0497US10752683B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2019·Granted Aug 25, 2020·13 cites·31 claims
- 0597US9670279B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted Jun 6, 2017·26 cites·118 claims
- 0697US9133275B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2013·Granted Sep 15, 2015·45 cites·44 claims
- 0796US9670280B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted Jun 6, 2017·19 cites·74 claims
- 0896US9670278B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted Jun 6, 2017·18 cites·104 claims
- 0996US9657100B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted May 23, 2017·16 cites·40 claims
- 1096US9598490B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2015·Granted Mar 21, 2017·18 cites·40 claims
- 1196US8557966B2Folate receptor 1 antibodies and immunoconjugates and uses thereofAB OLGA·Filed 2011·Granted Oct 15, 2013·89 cites·20 claims
- 1293US10301385B2Folate receptor 1 antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2017·Granted May 28, 2019·8 cites·28 claims
- 1391US7202346B2Antibodies to non-shed Muc1 and Muc16, and uses thereofIMMUNOGEN INC·Filed 2003·Granted Apr 10, 2007·62 cites·37 claims
- 1490US8137669B2Elimination of heterogeneous or mixed cell population in tumorsGOLDMAKHER VIKTOR S·Filed 2008·Granted Mar 20, 2012·7 cites·5 claims
- 1588US8840898B2Immunoconjugates targeting syndecan-1 expressing cells and use thereofGOLDMAKHER VIKTOR S·Filed 2007·Granted Sep 23, 2014·5 cites·10 claims
- 1688US8388960B2Elimination of heterogeneous or mixed cell population in tumorsGOLDMAKHER VIKTOR S·Filed 2011·Granted Mar 5, 2013·7 cites·3 claims
- 1780US6605426B1Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene productsAPOPTOSIS TECHNOLOGY INC·Filed 2000·Granted Aug 12, 2003·11 cites·11 claims
- 1875US2021032327A1Folate Receptor 1 Antibodies and Immunoconjugates and Uses ThereofIMMUNOGEN INC·Filed 2020·Application pending·0 cites
- 1972US2020408765A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI SA·Filed 2020·Application pending·0 cites
- 2068US2015010585A1Immunoconjugates targeting syndecan-1 expressing cells and use thereofBIOTEST AG·Filed 2014·Application pending·0 cites
- 2166US7449450B2Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene productsIMMUNOGEN INC·Filed 2005·Granted Nov 11, 2008·1 cites·19 claims
- 2264US2006233814A1Elimination of heterogeneous or mixed cell population in tumorsIMMUNOGEN INC·Filed 2006·Application pending·0 cites
- 2364US2006045877A1Immunoconjugates targeting syndecan-1 expressing cells and use thereofGOLDMAKHER VIKTOR S·Filed 2004·Application pending·0 cites
- 2462US6902885B2Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene productsAPOPTOSIS TECHNOLOGY INC·Filed 2003·Granted Jun 7, 2005·1 cites·17 claims
- 2560US2017343550A1Novel anti-cd38 antibodies for the treatment of cancerSANOFI SA·Filed 2017·Application pending·0 cites
- 2642US6218511B1Anti-apoptotic genes of human cytomegalovirus (HCMV) and their useAPOPTOSIS TECHNOLOGY INC·Filed 1998·Granted Apr 17, 2001·5 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Viktor S. Goldmakher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →